FULC
Fulcrum Therapeutics Inc
3.80$
-0.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +1,876.3% | +28.8% | +17.3% | +81.4% | -3.5% | +13.7% | +1.2% | +40.5% | |
| – | +5,437.7% | +35.1% | +12.8% | +100.2% | -8.2% | +16.7% | +3.2% | +43.0% | |
| – | +17,786.2% | +32.9% | -41.0% | -37.9% | -0.9% | -27.2% | +127.7% | +239.3% | |
| – | +17,786.2% | +32.9% | +16.8% | +93.2% | -7.0% | +16.4% | +2.0% | +46.2% | |
| – | +1,184.6% | -77.8% | +2,338.7% | +51.8% | -73.7% | +108.0% | +48.6% | -68.0% | |
| – | -23.8% | +432.2% | -193.5% | – | – | – | – | – | |
| – | +258.5% | -12.7% | -8.8% | -12.3% | -6.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +223.8% | +138.3% | +47.7% | -31.8% | +18.3% | -18.9% | -21.4% | -2.3% | |
| – | +51.8% | +187.1% | +120.1% | -28.2% | -12.9% | -18.2% | -19.2% | +18.1% | |
| – | – | +8.7% | -66.0% | +56,523.5% | -73.0% | -15.8% | -0.3% | +10.0% | |
| – | -24.5% | +73.1% | +86.6% | +17.4% | -24.0% | -24.2% | -57.8% | +36.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +5,648.9% | +14.7% | +9.2% | +122.2% | -6.0% | +18.2% | +3.3% | +43.6% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +33.8% | +11.9% | +39.5% | +27.2% | +36.3% | +1.1% | +2.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.